291 related articles for article (PubMed ID: 12595840)
1. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial.
Gurbel PA; Cummings CC; Bell CR; Alford AB; Meister AF; Serebruany VL;
Am Heart J; 2003 Feb; 145(2):239-47. PubMed ID: 12595840
[TBL] [Abstract][Full Text] [Related]
2. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Barrera-Ramirez C; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Thromb Res; 2005; 115(1-2):101-8. PubMed ID: 15567460
[TBL] [Abstract][Full Text] [Related]
3. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
[TBL] [Abstract][Full Text] [Related]
4. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study.
L'Allier PL; Ducrocq G; Pranno N; Noble S; Ibrahim R; Grégoire JC; Azzari F; Nozza A; Berry C; Doucet S; Labarthe B; Théroux P; Tardif JC;
J Am Coll Cardiol; 2008 Mar; 51(11):1066-72. PubMed ID: 18342223
[TBL] [Abstract][Full Text] [Related]
6. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
Hochholzer W; Trenk D; Frundi D; Blanke P; Fischer B; Andris K; Bestehorn HP; Büttner HJ; Neumann FJ
Circulation; 2005 May; 111(20):2560-4. PubMed ID: 15809367
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
8. Uniform platelet activation exists before coronary stent implantation despite aspirin therapy.
Serebruany VL; Cummings CC; Malinin AI; Steinhubl SR; Gurbel PA
Am Heart J; 2001 Oct; 142(4):611-6. PubMed ID: 11579350
[TBL] [Abstract][Full Text] [Related]
9. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
Kastrati A; von Beckerath N; Joost A; Pogatsa-Murray G; Gorchakova O; Schömig A
Circulation; 2004 Oct; 110(14):1916-9. PubMed ID: 15262828
[TBL] [Abstract][Full Text] [Related]
10. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.
Angiolillo DJ; Fernández-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Bañuelos C; Hernández-Antolín R; Escaned J; Moreno R; Alfonso F; Macaya C
Eur Heart J; 2004 Nov; 25(21):1903-10. PubMed ID: 15522469
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?
Angiolillo DJ; Fernández-Ortiz A; Bernardo E; Barrera Ramírez C; Sabaté M; Fernandez C; Hernández-Antolín R; Escaned J; Alfonso F; Macaya C
J Invasive Cardiol; 2004 Apr; 16(4):169-74. PubMed ID: 15152138
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Failure of clopidogrel to reduce platelet reactivity and activation following standard dosing in elective stenting: implications for thrombotic events and restenosis.
Gurbel PA; Samara WM; Bliden KP
Platelets; 2004 Mar; 15(2):95-9. PubMed ID: 15154601
[TBL] [Abstract][Full Text] [Related]
14. Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
Sacristán D; López-Farré AJ; Zamorano-León JJ; Azcona L; Fernández-Ortiz A; Romero J; Farré J; Macaya C
J Cardiovasc Pharmacol; 2008 Mar; 51(3):286-92. PubMed ID: 18356694
[TBL] [Abstract][Full Text] [Related]
15. Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
Weltermann A; Fritsch P; Kyrle PA; Schoenauer V; Heinze G; Wojta J; Christ G; Huber K
Thromb Res; 2003; 112(1-2):19-24. PubMed ID: 15013268
[TBL] [Abstract][Full Text] [Related]
16. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
17. Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
Collet JP; Silvain J; Landivier A; Tanguy ML; Cayla G; Bellemain A; Vignolles N; Gallier S; Beygui F; Pena A; Montalescot G
Circulation; 2008 Sep; 118(12):1225-33. PubMed ID: 18765393
[TBL] [Abstract][Full Text] [Related]
18. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
19. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A
Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639
[TBL] [Abstract][Full Text] [Related]
20. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.
Lepäntalo A; Virtanen KS; Heikkilä J; Wartiovaara U; Lassila R
Eur Heart J; 2004 Mar; 25(6):476-83. PubMed ID: 15039127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
